CN1695719A - Chinese traditional medicine for preventing and treating cancer - Google Patents
Chinese traditional medicine for preventing and treating cancer Download PDFInfo
- Publication number
- CN1695719A CN1695719A CN 200510025412 CN200510025412A CN1695719A CN 1695719 A CN1695719 A CN 1695719A CN 200510025412 CN200510025412 CN 200510025412 CN 200510025412 A CN200510025412 A CN 200510025412A CN 1695719 A CN1695719 A CN 1695719A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- isatidis
- chinese medicine
- flower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for preventing and treating cancers is prepared from 35 Chinese-medicinal materials including honeysuckle flower, wild chrysanthemum flower, rehmannia root, astragalus root, etc.
Description
Technical field:
The present invention relates to a kind of prevention and also can treat the Chinese medicine of cancer, particularly a kind of is the pure Chinese medicine composition that prevents and can treat cancer and tumor that raw material is made with the vegetable Chinese herbal medicine, hepatocarcinoma, pulmonary carcinoma, gastric cancer, intestinal cancer, breast carcinoma, lymphatic cancer, uterus carcinoma is had prevent preferably and therapeutic effect.
Background technology:
Add up according to World Health Organization (WHO), the sickness rate of various cancers and tumor is the trend that rises year by year, hepatocarcinoma particularly, pulmonary carcinoma, gastric cancer, intestinal cancer, breast carcinoma, lymphatic cancer, uterus carcinoma, human health is threatened maximum, up to the present, still there is not a kind of specially good effect good medicine for the treatment of cancer and tumor in the world, present Therapeutic Method is to early, mid-term, cancer and tumor patient were carried out operative treatment, chemotherapy, the bonded complex treatment measure of Chinese medicine and western medicine, although obtained certain curative effect, it also only is the effect of playing relief of symptoms, for the late malignant tumour patient, lack especially effectively Therapeutic Method, anticancer Western medicine commonly used has interferon, interleukin, cisplatin, 5-fluorouracil etc., the effect that these medicines have is undesirable, the side effect that has is too big, Chinese medicine anticarcinogen commonly used generally is a medicine targetedly, as FUFANG TIANXIAN WAN is medicine at alimentary tract cancer, at present shortage can be treated the medicine of multiple cancer and tumor, does not have more a kind ofly can prevent hepatocarcinoma, pulmonary carcinoma, gastric cancer, intestinal cancer, breast carcinoma, lymphatic cancer, the prevention kind anti-cancer drugs thing of uterus carcinoma.
Summary of the invention:
The object of the present invention is to provide a kind of Chinese medicine that can effectively prevent and can treat cancer.
Technical scheme of the present invention is according to the generation of motherland's traditional medicine to cancer and tumor, development and pathogeny that shifts and Therapeutic Principle's understanding, gain knowledge in conjunction with modern medical knowledge, from motherland's medical treasure-house, filter out and have no side effect, can restrain the generation of cancerous cell and tumor, development, shift, recurrence, safeguard the allomeric function of body, and energy activating blood circulation to dissipate blood stasis, regulating QI to relieve pain, hard masses softening and resolving, heat-clearing and toxic substances removing, strengthening the body resistance, supplying vital essence and marrow, the vegetable Chinese herbal medicine of the QI invigorating that nourishes blood, press Chinese medicine medical science opinion prescription, develop anticancer pharmaceutical composition of the present invention, after taking, can make human body constantly produce anticancer blood, blood can be flowed through whole body, prevents the generation of cancerous cell and tumor for a long time.
To achieve these goals, technical scheme of the present invention is: a kind of prevention also can be treated the Chinese medicine of cancer, it is characterized in that: described Chinese medicine is by Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, Typhonium flagelliforme (Lodd.) Blume is formed, and its mass percent is: Herba Taraxaci 2.3-2.9%, Flos Lonicerae 2.3-2.9%, Flos Chrysanthemi Indici 2.3-2.9%, Herba Violae 2.3-2.9%, Radix Semiaquilegiae 2.3-2.9%, Folium Isatidis 2.3-2.9%, Radix Rehmanniae 2.3-2.9%, Radix Rehmanniae Preparata 2.3-2.9%, Squama Manis 2.3-2.9%, Spina Gleditsiae 2.3-2.9%, Bulbus Fritillariae Uninbracteatae 2.3-2.9%, A flower of Radix Dichroae 2.3-2.9%, Herba Scutellariae Barbatae 2.3-2.9%, Radix Isatidis 5-5.7%, Herba Houttuyniae 5-5.7%, Radix Scrophulariae 5-5.7%, Radix Astragali 5-5.7%, Radix Salviae Miltiorrhizae 5-5.7%, Fructus Lycii 5-5.7%, Radix Paeoniae Alba 5-5.7%, pollen 5-5.7%, Herba Hedyotidis Diffusae 5-5.7%, Colla Corii Asini 1.99-2.5%, Cornu Cervi 1.99-2.5%, Carapax et Plastrum Testudinis 1.99-2.5%, Radix Angelicae Sinensis 1.3-1.7%, Radix Ginseng 1.3-1.7%, rhizoma sparganic 1.3-1.7%, Rhizoma Curcumae 1.3-1.7%, Scorpio 1.3-1.7%, Hirudo 1.3-1.7%, Radix Angelicae Dahuricae 1.3-1.7%, Radix Paeoniae Rubra 1.3-1.7%, Scolopendra 0.02-0.05%, Typhonium flagelliforme (Lodd.) Blume 0.51-0.92%.
The present invention is according to motherland's Traditional Chinese medical theory, and gain knowledge in conjunction with modern medical knowledge, from motherland's medical treasure-house, filter out and have no side effect, can restrain the generation of cancerous cell and tumor, development, shift, recurrence, safeguard the allomeric function of body, and energy activating blood circulation to dissipate blood stasis, regulating QI to relieve pain, hard masses softening and resolving, heat-clearing and toxic substances removing, strengthening the body resistance, supplying vital essence and marrow, the vegetable Chinese herbal medicine of the QI invigorating that nourishes blood, adopt modern pharmaceutical technology to make medicament, its the most outstanding substantive distinguishing features is to kill the cancerous cell that is in bud, avoided the generation of middle and terminal cancer, this medicament only needed take two courses of treatment in 1 year, about about 10 days of each course of treatment, twice on the one, effect is remarkable, not only have no side effect, also can consolidate and keep fit, the present invention proposes a kind of new anticancer theory, to put prevention first, just can effectively control and kill initial stage hepatocarcinoma at the cancer initial stage, pulmonary carcinoma, gastric cancer, intestinal cancer, breast carcinoma, lymphatic cancer, the cancerous cell of uterus carcinoma, in need not developing into by the time, terminal cancer is being treated, make cancer patient and family numbers of patients not be used in and bear mentally and burden economically, so the present invention has outstanding substantive distinguishing features and obvious improvement with respect to existing cancer therapy drug.
The invention discloses a kind of prevention and also can treat the Chinese medicine of cancer, its difference prior art is: described Chinese medicine is by Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, Typhonium flagelliforme (Lodd.) Blume is formed, and its mass percent is: Herba Taraxaci 2.3-2.9%, Flos Lonicerae 2.3-2.9%, Flos Chrysanthemi Indici 2.3-2.9%, Herba Violae 2.3-2.9%, Radix Semiaquilegiae 2.3-2.9%, Folium Isatidis 2.3-2.9%, Radix Rehmanniae 2.3-2.9%, Radix Rehmanniae Preparata 2.3-2.9%, Squama Manis 2.3-2.9%, Spina Gleditsiae 2.3-2.9%, Bulbus Fritillariae Uninbracteatae 2.3-2.9%, A flower of Radix Dichroae 2.3-2.9%, Herba Scutellariae Barbatae 2.3-2.9%, Radix Isatidis 5-5.7%, Herba Houttuyniae 5-5.7%, Radix Scrophulariae 5-5.7%, Radix Astragali 5-5.7%, Radix Salviae Miltiorrhizae 5-5.7%, Fructus Lycii 5-5.7%, Radix Paeoniae Alba 5-5.7%, pollen 5-5.7%, Herba Hedyotidis Diffusae 5-5.7%, Colla Corii Asini 1.99-2.5%, Cornu Cervi 1.99-2.5%, Carapax et Plastrum Testudinis 1.99-2.5%, Radix Angelicae Sinensis 1.3-1.7%, Radix Ginseng 1.3-1.7%, rhizoma sparganic 1.3-1.7%, Rhizoma Curcumae 1.3-1.7%, Scorpio 1.3-1.7%, Hirudo 1.3-1.7%, Radix Angelicae Dahuricae 1.3-1.7%, Radix Paeoniae Rubra 1.3-1.7%, Scolopendra 0.02-0.05%, Typhonium flagelliforme (Lodd.) Blume 0.51-0.92%.
In an embodiment of the present invention, the mass percent of Chinese medicine is a Herba Taraxaci 2.5%, Flos Lonicerae 2.5%, Flos Chrysanthemi Indici 2.5%, Herba Violae 2.5%, Radix Semiaquilegiae 2.5%, Folium Isatidis 2.5%, the Radix Rehmanniae 2.5%, Radix Rehmanniae Preparata 2.6%, Squama Manis 2.6%, Spina Gleditsiae 2.6%, Bulbus Fritillariae Uninbracteatae 2.6%, A flower of Radix Dichroae 2.6%, Herba Scutellariae Barbatae 2.6%, Radix Isatidis 5.3%, Herba Houttuyniae 5.3%, Radix Scrophulariae 5.3%, the Radix Astragali 5.3%, Radix Salviae Miltiorrhizae 5.3%, Fructus Lycii 5.3%, the Radix Paeoniae Alba 5.3%, pollen 5.3%, Herba Hedyotidis Diffusae 5.3%, Colla Corii Asini 2.13%, Cornu Cervi 2.13%, Carapax et Plastrum Testudinis 2.13%, Radix Angelicae Sinensis 1.51%, Radix Ginseng 1.51%, rhizoma sparganic 1.51%, Rhizoma Curcumae 1.51%, Scorpio 1.51%, Hirudo 1.51%, the Radix Angelicae Dahuricae 1.51%, Radix Paeoniae Rubra 1.51%, Scolopendra 0.03%, Typhonium flagelliforme (Lodd.) Blume 0.7%.
In another embodiment of the present invention, the mass percent of Chinese medicine is a Herba Taraxaci 2.3%, Flos Lonicerae 2.6%, Flos Chrysanthemi Indici 2.6%, Herba Violae 2.5%, Radix Semiaquilegiae 2.3%, Folium Isatidis 2.6%, the Radix Rehmanniae 2.6%, Radix Rehmanniae Preparata 2.6%, Squama Manis 2.6%, Spina Gleditsiae 2.6%, Bulbus Fritillariae Uninbracteatae 2.6%, A flower of Radix Dichroae 2.6%, Herba Scutellariae Barbatae 2.6%, Radix Isatidis 5.3%, Herba Houttuyniae 5.3%, Radix Scrophulariae 5.3%, the Radix Astragali 5.3%, Radix Salviae Miltiorrhizae 5.3%, Fructus Lycii 5.3%, the Radix Paeoniae Alba 5.3%, pollen 5.3%, Herba Hedyotidis Diffusae 5.3%, Colla Corii Asini 2.13%, Cornu Cervi 2.13%, Carapax et Plastrum Testudinis 2.13%, Radix Angelicae Sinensis 1.51%, Radix Ginseng 1.5%, rhizoma sparganic 1.52%, Rhizoma Curcumae 1.51%, Scorpio 1.5%, Hirudo 1.41%, the Radix Angelicae Dahuricae 1.41%, Radix Paeoniae Rubra 1.5%, Scolopendra 0.03%, Typhonium flagelliforme (Lodd.) Blume 0.92%.
This Chinese medicine can be made into close ball, close ball is the pill of making as binding agent with the Mel of refining, earlier with Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, this 30 Chinese medicine of the five flavours of Typhonium flagelliforme (Lodd.) Blume is through screening, microwave sterilizating, dry, fine grinding, make medicated powder, mix with the Mel of refining again, the mass percent of Chinese medicine is a Herba Taraxaci 2.5%, Flos Lonicerae 2.5%, Flos Chrysanthemi Indici 2.5%, Herba Violae 2.5%, Radix Semiaquilegiae 2.5%, Folium Isatidis 2.5%, the Radix Rehmanniae 2.5%, Radix Rehmanniae Preparata 2.6%, Squama Manis 2.6%, Spina Gleditsiae 2.6%, Bulbus Fritillariae Uninbracteatae 2.6%, A flower of Radix Dichroae 2.6%, Herba Scutellariae Barbatae 2.6%, Radix Isatidis 5.3%, Herba Houttuyniae 5.3%, Radix Scrophulariae 5.3%, the Radix Astragali 5.3%, Radix Salviae Miltiorrhizae 5.3%, Fructus Lycii 5.3%, the Radix Paeoniae Alba 5.3%, pollen 5.3%, Herba Hedyotidis Diffusae 5.3%, Colla Corii Asini 2.13%, Cornu Cervi 2.13%, Carapax et Plastrum Testudinis 2.13%, Radix Angelicae Sinensis 1.51%, Radix Ginseng 1.51%, rhizoma sparganic 1.51%, Rhizoma Curcumae 1.51%, Scorpio 1.51%, Hirudo 1.51%, the Radix Angelicae Dahuricae 1.51%, Radix Paeoniae Rubra 1.51%, Scolopendra 0.03%, Typhonium flagelliforme (Lodd.) Blume 0.7%, because Mel contains the multiple nutritional components of needed by human, thereby to weak and sickly, the anemia of pregnant woman, childhood development, constipation, xerosis cutis, wrinkle, withered and yellow and the multiple chronic disease nourishing of hair is the most suitable.
The processing technology of the close ball of Chinese medicine:
1, Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, Typhonium flagelliforme (Lodd.) Blume are crossed the 100-120 mesh sieve through screening, microwave sterilizating, drying, fine grinding
2, with Chinese medicine fine powder and the Mel uniform mixing of refining, make soft material, the consumption of Mel is looked the consumption of Chinese medicine fine powder, and the ratio of general Chinese medicine fine powder and Mel is 1: 1-1: 1.5, and for example per 100 gram fine powders add 115 gram Mel.
3, soft material gradation is made pill, every ball 6 grams.
This Chinese medicine also can be made into oral liquid, and oral liquid adds Chinese medicine a kind of sterilization or half oral liquid formulations of sterilizing that suitable additive is made earlier after suitably extracting, making with extra care.
The technology that oral liquid is made:
1, extract: common extracting method is by decocting method, the way of distillation, percolation, continuous backflow extraction method, and these methods all belong to prior art, does not belong to content of the present invention, does not do detailed description at this.
2, concentrated and precipitate with ethanol: after fried liquid of Chinese medicine and press liquor merging filtration, use the concentrating under reduced pressure method, be concentrated into every ml medicinal liquid and contain 1-2 gram crude drug, or relative density adds 95% ethanol during (80 degree) left and right sides 1.20, makes medicinal liquid contain amount of alcohol and reaches 60%-75%, and quiescent setting is more than 48 hours, when adding ethanol, should repeatedly add on a small quantity, and the stirring of limit edged, in order to avoid precipitation produces.
3, reclaim ethanol and batching: the medicine alcoholic liquor decompression recycling ethanol after will filtering, add additive, as the agent of tender flavor, simple syrup, Mel etc., its amount is controlled at about 20%, antiseptic such as sodium benzoate, Crataegolic acid etc., its content is generally about 0.3%.
4, fill and sterilization: under sterilising conditions, with the fill of oral liquid production line automatic filling machine, with the product after the fill through high pressure steam sterilization 30 seconds.Cooling, inspection have or not the breakage of loading amount sum of errors, then the labeling packing.
Claims (2)
1, a kind of prevention also can be treated the Chinese medicine of cancer, it is characterized in that: described Chinese medicine is by Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, Typhonium flagelliforme (Lodd.) Blume is formed, and its mass percent is: Herba Taraxaci 2.3-2.9%, Flos Lonicerae 2.3-2.9%, Flos Chrysanthemi Indici 2.3-2.9%, Herba Violae 2.3-2.9%, Radix Semiaquilegiae 2.3-2.9%, Folium Isatidis 2.3-2.9%, Radix Rehmanniae 2.3-2.9%, Radix Rehmanniae Preparata 2.3-2.9%, Squama Manis 2.3-2.9%, Spina Gleditsiae 2.3-2.9%, Bulbus Fritillariae Uninbracteatae 2.3-2.9%, A flower of Radix Dichroae 2.3-2.9%, Herba Scutellariae Barbatae 2.3-2.9%, Radix Isatidis 5-5.7%, Herba Houttuyniae 5-5.7%, Radix Scrophulariae 5-5.7%, Radix Astragali 5-5.7%, Radix Salviae Miltiorrhizae 5-5.7%, Fructus Lycii 5-5.7%, Radix Paeoniae Alba 5-5.7%, pollen 5-5.7%, Herba Hedyotidis Diffusae 5-5.7%, Colla Corii Asini 1.99-2.5%, Cornu Cervi 1.99-2.5%, Carapax et Plastrum Testudinis 1.99-2.5%, Radix Angelicae Sinensis 1.3-1.7%, Radix Ginseng 1.3-1.7%, rhizoma sparganic 1.3-1.7%, Rhizoma Curcumae 1.3-1.7%, Scorpio 1.3-1.7%, Hirudo 1.3-1.7%, Radix Angelicae Dahuricae 1.3-1.7%, Radix Paeoniae Rubra 1.3-1.7%, Scolopendra 0.02-0.05%, Typhonium flagelliforme (Lodd.) Blume 0.51-0.92%.
2, a kind of prevention according to claim 1 also can be treated the Chinese medicine of cancer, it is characterized in that: described Chinese medicine is by Herba Taraxaci, Flos Lonicerae, Flos Chrysanthemi Indici, Herba Violae, Radix Semiaquilegiae, Folium Isatidis, the Radix Rehmanniae, Radix Rehmanniae Preparata, Squama Manis, Spina Gleditsiae, Bulbus Fritillariae Uninbracteatae, A flower of Radix Dichroae, Herba Scutellariae Barbatae, Radix Isatidis, Herba Houttuyniae, Radix Scrophulariae, the Radix Astragali, Radix Salviae Miltiorrhizae, Fructus Lycii, the Radix Paeoniae Alba, pollen, Herba Hedyotidis Diffusae, Colla Corii Asini, Cornu Cervi, Carapax et Plastrum Testudinis, Radix Angelicae Sinensis, Radix Ginseng, rhizoma sparganic, Rhizoma Curcumae, Scorpio, Hirudo, the Radix Angelicae Dahuricae, Radix Paeoniae Rubra, Scolopendra, Typhonium flagelliforme (Lodd.) Blume is formed, and its mass percent is: Herba Taraxaci 2.6%, Flos Lonicerae 2.6%, Flos Chrysanthemi Indici 2.6%, Herba Violae 2.6%, Radix Semiaquilegiae 2.6%, Folium Isatidis 2.6%, the Radix Rehmanniae 2.6%, Radix Rehmanniae Preparata 2.6%, Squama Manis 2.6%, Spina Gleditsiae 2.6%, Bulbus Fritillariae Uninbracteatae 2.6%, A flower of Radix Dichroae 2.6%, Herba Scutellariae Barbatae 2.6%, Radix Isatidis 5.3%, Herba Houttuyniae 5.3%, Radix Scrophulariae 5.3%, the Radix Astragali 5.3%, Radix Salviae Miltiorrhizae 5.3%, Fructus Lycii 5.3%, the Radix Paeoniae Alba 5.3%, pollen 5.3%, Herba Hedyotidis Diffusae 5.3%, Colla Corii Asini 2.13%, Cornu Cervi 2.13%, Carapax et Plastrum Testudinis 2.13%, Radix Angelicae Sinensis 1.51%, Radix Ginseng 1.51%, rhizoma sparganic 1.51%, Rhizoma Curcumae 1.51%, Scorpio 1.51%, Hirudo 1.51%, the Radix Angelicae Dahuricae 1.51%, Radix Paeoniae Rubra 1.51%, Scolopendra 0.03%, Typhonium flagelliforme (Lodd.) Blume 0.72%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510025412 CN1695719A (en) | 2005-04-26 | 2005-04-26 | Chinese traditional medicine for preventing and treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510025412 CN1695719A (en) | 2005-04-26 | 2005-04-26 | Chinese traditional medicine for preventing and treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1695719A true CN1695719A (en) | 2005-11-16 |
Family
ID=35348708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510025412 Pending CN1695719A (en) | 2005-04-26 | 2005-04-26 | Chinese traditional medicine for preventing and treating cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1695719A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804142B (en) * | 2010-02-04 | 2011-07-20 | 罗启淼 | Traditional Chinese medicine composition for treating carcinoma of uterine body |
| CN102526431A (en) * | 2012-03-29 | 2012-07-04 | 翟西菊 | Traditional Chinese medicine preparation for treating gastric cancer and preparation method |
| CN103735957A (en) * | 2013-12-25 | 2014-04-23 | 韩明辉 | Chinese herbal medicine formula for treating benign tumors in lung and preparation method thereof |
| CN104474146A (en) * | 2014-12-17 | 2015-04-01 | 陈瑞莲 | Medicine for treating liver cancer and preparation method of medicine |
| CN105250911A (en) * | 2015-10-28 | 2016-01-20 | 韩广成 | Traditional Chinese medicine preparation for preventing and treating cancer and preparation method thereof |
| CN106729328A (en) * | 2017-02-17 | 2017-05-31 | 王政和 | A kind of Chinese medicine composition for the treatment of cancer and its application |
| CN108186899A (en) * | 2018-03-07 | 2018-06-22 | 韦雄悬 | A kind of Chinese medicine composition for treating tumour and preparation method and application |
| CN111494531A (en) * | 2020-06-23 | 2020-08-07 | 吴瑞谦 | Traditional Chinese medicine for preventing and treating tumor and cancer and preparation method thereof |
-
2005
- 2005-04-26 CN CN 200510025412 patent/CN1695719A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804142B (en) * | 2010-02-04 | 2011-07-20 | 罗启淼 | Traditional Chinese medicine composition for treating carcinoma of uterine body |
| CN102526431A (en) * | 2012-03-29 | 2012-07-04 | 翟西菊 | Traditional Chinese medicine preparation for treating gastric cancer and preparation method |
| CN102526431B (en) * | 2012-03-29 | 2013-10-16 | 翟西菊 | Traditional Chinese medicine preparation for treating gastric cancer and preparation method |
| CN103735957A (en) * | 2013-12-25 | 2014-04-23 | 韩明辉 | Chinese herbal medicine formula for treating benign tumors in lung and preparation method thereof |
| CN104474146A (en) * | 2014-12-17 | 2015-04-01 | 陈瑞莲 | Medicine for treating liver cancer and preparation method of medicine |
| CN105250911A (en) * | 2015-10-28 | 2016-01-20 | 韩广成 | Traditional Chinese medicine preparation for preventing and treating cancer and preparation method thereof |
| CN106729328A (en) * | 2017-02-17 | 2017-05-31 | 王政和 | A kind of Chinese medicine composition for the treatment of cancer and its application |
| CN108186899A (en) * | 2018-03-07 | 2018-06-22 | 韦雄悬 | A kind of Chinese medicine composition for treating tumour and preparation method and application |
| CN111494531A (en) * | 2020-06-23 | 2020-08-07 | 吴瑞谦 | Traditional Chinese medicine for preventing and treating tumor and cancer and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN1695719A (en) | Chinese traditional medicine for preventing and treating cancer | |
| CN100469384C (en) | Chinese medicinal decoction for treating leucopenia caused by cancer radiochemical therapy and method for preparing same | |
| CN104352608B (en) | A kind of benefiting QI for activating blood circulation, hard masses softening and resolving, the Chinese medicine and preparation method thereof of removing toxic substances pain relieving | |
| CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
| CN101130023A (en) | Powder of codonopsis pilosula for warming stomach | |
| CN103977217A (en) | Medicinal composition for treating renal carcinoma | |
| CN103933450A (en) | Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition | |
| CN103028077A (en) | Traditional Chinese medicine preparation for treating tumors | |
| CN102579677B (en) | Chinese medicinal composition for treating brain glioma | |
| CN101843723B (en) | Chinese medicament for treating abnormal menstruation | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN105396022A (en) | Preparation method of pharmaceutical tablet alleviating tumor patient radiotherapy reaction | |
| CN102302606A (en) | Chinese medicament for treating chronic prostatitis | |
| CN102379965A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102389531A (en) | Traditional Chinese medicine for curing chronic prostatitis | |
| CN101961416A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN106692821A (en) | Traditional Chinese medicine preparation for treating neurosurgical postoperative headache | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101554426B (en) | Traditional Chinese medicine for treating diabetic obstipation | |
| CN100522197C (en) | Chinese-medicinal preparation for treating high blood fat and its making method | |
| CN101129700A (en) | Five-flavor yam pill | |
| CN1686472A (en) | Chinese medicinal product for protecting liver and freezing bowel | |
| CN104623506A (en) | Traditional Chinese medicine for treating infertility gynaecopathia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |